High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy
Abstract Adenoviruses are very efficient vectors for delivering therapeutic genes in preclinical and clinical trials. However, randomized controlled human trials have often been lacking clear clinically relevant results. We hypothesized that high lipid levels and specific lipoproteins could signific...
Enregistré dans:
Auteurs principaux: | A. M. Kivelä, J. Huusko, E. Gurzeler, A. Laine, M. H. Dijkstra, G. Dragneva, C. B. F. Andersen, S. K. Moestrup, S. Ylä-Herttuala |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/13eec640ea744d0e8b268a995fb998d0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice.
par: Erika Gurzeler, et autres
Publié: (2021) -
SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice
par: Erika Gurzeler, et autres
Publié: (2021) -
A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition.
par: Neda Bagheri, et autres
Publié: (2011) -
Epigenetic upregulation of endogenous VEGF-A reduces myocardial infarct size in mice.
par: Mikko P Turunen, et autres
Publié: (2014) -
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses.
par: Anna Kanerva, et autres
Publié: (2008)